type 1 diabetic patients who have endured their condition for prolonged periods are not uncommon, but there are few well-documented cases of type 2 diabetic patients with duration of over fifty years. In the present case study, we analyzed the history of a diabetic patient whose duration was 53 years. Her case was consequently diagnosed not as the common type 2 diabetes, but as the slowly progressive type 1 diabetes (SPIDDM) identified by Japanese medical researchers. The patient, now 73 years old, was first diagnosed with diabetes in 1953 when she was 17 years of age and started insulin injections. In 1962 she was referred to our hospital, and two years later she vaginally delivered a healthy baby (birth weight 3100 g) at the 40 th week of gestation. She was the first case of a diabetic mother delivering an infant treated at Tokyo Women's Medical College Hospital. Her data shows that her C-peptide responses by meal tolerance test in 1978 was at least partly preserved though it decreased year by year. Her anti-GAD antibody was found to be positive in 2000 and remained so in 2009. This leads us to conclude that the etiology of her SPIDDM was most likely has insulin secretion exhaustion.
Slowly progreSSive type 1 diAbeteS (SPIDDM), a subtype of type 1 diabetes, was first proposed by Kobayashi et al. in 1982 [1] . The case described here was the first diabetic pregnant woman to deliver a child at tokyo women's medical College (TWMC) Hospital. She had been treated as type 2 diabetes for over fifty years because of her family history and low dosage of insulin requirement during pregnancy. Recently her diagnosis was revised to sPiddm because of her positive anti-gad antibody and exhausted insulin secretion.
Case report
The patient is a 73 years old housewife. She has 8 siblings and is a fraternal twin. Her fraternal twin brother developed type 2 diabetes at the age of 70. Her first son had type 2 diabetes at 40 years old.
In 1953, at the age of 17, she was diagnosed as having diabetes in Hokkaido, Japan. Upon admission, she started taking regular insulin injections three times a day. She was hospitalized for 13 months to control her glucose metabolism.
In 1956, she graduated from nutritional college, and worked at a university as a member of the administration staff.
In 1961, she got married and moved to Tokyo. In 1962, she was introduced to TWMC Hospital. At that time, she was put on a regimen of a single daily injection of 14 units NPH insulin. Her height was 154 cm, body weight 46 kg, body mass index 19.4 kg/m 2 and blood pressure 114/60 mmHg. She continued her NPH insulin injection regimen at the same dosage.
In 1964, she had a male baby whose birth weight was 3100 g at the 40 th week of gestation by natural delivery. She was the first diabetic woman ever to deliver a baby at TWMC Hospital. In 1967, she had a Note DRB1*040501/-, DQB1*0401/-. The patient has the highly susceptible gene to Japanese type 1 diabetes [3] .
The titer of anti-GAD antibody was 2.6 unit/mL in 2000, 2.3 unit/mL in 2007 and 6.0 unit/mL in 2009.
Ct image of her pancreas showed no fat cell infiltration in the pancreas parenchyma and no atrophy of her pancreas, thus the state of her pancreas corresponded to her age. discussion the characteristics of sPiddm are: 1) positive anti-gad antibodies for a long time, 2) at the beginning of this disease, patients have insulin secretion the same as type 2 diabetes, 3) the patient's hyperglycemia can be treated by oral hypoglycemic agents at the beginning of onset, 4) finally, the patient's insulin secretion disappears and thus insulin injections are required [1] .
our patient was diagnosed as having diabetes at the age of 17, and her β-cell function was preserved for a long time. Finally, her insulin secretion was exhausted and her positive anti-gad antibody was documented. These facts support the hypothesis that her type of diabetes was SPIDDM.
a typical case of sPiddm does not need insulin injection for survival at the onset of disease. This woman started insulin injections when her diabetes was diagnosed, because she was young and planned her second healthy female baby of 3700 g at the 40 th week under the same condition. Her glycemic control during the two pregnancies was almost normal and her insulin dosage did not change. table 1 shows that her chronological insulin secretion at meal tolerance test containing 450 kcal, which is a typical Japanese breakfast. Using the technique for measuring C-peptide reactivity (CPr) developed by Kaneko et al. in 1974 [2] , the examination of the CPR response of this patient begun in 1978 showed that it was present at minimal level.
Year by year, however, her CPR response declined and finally it became almost nonexistent. Even though her insulin requirement was proportionately increased to about 40 units a day, her glycemic control did not improve. she used insulin glargine and insulin aspart, with a daily dosage of 50 units, but her glycated hemoglobin (HbA1c) was around 8% in 2006.
She has had no nephropathy since 1953. Until 1995, her retinopathy was simple background. It changed to proliferative retinopathy and she received photocoagulation therapy in 1997. In 1985, she developed hyperthyroidism. Her thyroid test was negative, and microsome test 12800x at the point. After 131 i therapy, she developed hypothyroidism. She is presently taking thyroxine (thyradin SR 100 μg per day) to maintain normal thyroid function.
The serological HLA type of this patient is A24, B54 and DR4 and HLA genotype is HLA- Meal tolerance test containing 450 kcal. *CPr; C-peptide reactivity dependent state [1, 6] . Autoimmune diabetes, both SPIDDM and LADA, includes a very wide spectrum of clinical feature and stages. It is sometimes difficult to determine the type of diabetes. this patient delivered two healthy babies in the course of SPIDDM and the progression of β-cell failure was observed. Whenever we treat type 2 diabetic patients who require insulin, it is important to consider pancreatic insulin secretion exhaustion as a possible cause of the decline of type 2 diabetes or SPIDDM.
this case report was presented in part at 5 th international symposium on diabetes and Pregnancy in Sorrento, Italy.
